Chinese Version

Latest Issue

Issue Browsing Column Browsing

Issue 03 ， 2022

The effect of 3% diquafosol on the improvement of ocular surface post cataract surgery: A meta-analysis for time of intervention Cover Article Back Cover Article Enhanced Publication
Yuhang Zhang,Ying Qi,Xiaohang Xie,Fengyan Zhang
Vol.2 , Issue 3 (2022) DOI：10.1016/j.aopr.2022.100063

Abstract：PurposeThe effect of interventional time for 3% Diquafosol reatment in post-cataract surgery has not been well established. A meta-analysis was performed to evaluate the improvement of ocular surface condition in post-cataract surgery patients who received 3% DQS for various treatment durations.
Keywords：Diquafosol,Cataractsurgery,Ocularsurface,Meta-analysis
6

|

0

|

0

<HTML>
<CITATION> <Bulk Citation> 2022061568520087 false

Published：2022-08-14
Eyelid squamous cell carcinoma in the setting of epidermodysplasia verruciformis (EV) diagnosed by next-generation sequencing: A case report and literature review Cover Article Back Cover Article Enhanced Publication
Linyan Wang,Hong Fang,An Shao,Huina Zhang,Juan Ye
Vol.2 , Issue 3 (2022) DOI：10.1016/j.aopr.2022.100066

0

|

0

|

0

<HTML>
<CITATION> <Bulk Citation> 2022081369139359 false

Published：2022-08-14
Changes of Beclin-1 and ULK1 in retina of mice model in oxygen-inducedretinopathy Cover Article Back Cover Article Enhanced Publication
Jie Wang,Ergang Du,FeiFei Li,Yunliang Zheng
Vol.2 , Issue 3 (2022) DOI：10.1016/j.aopr.2022.100065

Abstract：PurposeTo observe the expression differences and potential effects of autophagy-related Beclin1 (mammalian Atg6) and Uncoordinated-51 like kinase 1 (ULK1) in the oxygen-induced retinopathy (OIR) model.
Keywords：Retinopathyofprematurity,Autophagy,Retina,Beclin1,Uncoordinated-51likekinase1(ULK1)
0

|

0

|

0

<HTML>
<CITATION> <Bulk Citation> 2022071468621265 false

Published：2022-08-14
Efficacy and safety of monoclonal antibodies in neuromyelitis optica spectrum disorders: A survival meta-analysis of randomized controlled trials Cover Article Back Cover Article Enhanced Publication
Xintong Xu,Lindan Xie,Lili Wei,Meixuan Li,Hao Wang,Huanfen Zhou,Mingming Sun,Mo Yang,Quangang Xu,Kehu Yang,Shihui Wei
Vol.2 , Issue 3 (2022) DOI：10.1016/j.aopr.2022.100064

Abstract：BackgroundMonoclonal antibodies such as rituximab (RTX), eculizumab, inebilizumab, satralizumab, and tocilizumab have been found to be effective therapies for neuromyelitis optica spectrum disease (NMOSD) in several clinical randomized controlled trials.
Keywords：NMOSD,Randomizedcontrolledtrials,Monoclonalantibody,Meta-analysis,Free-relapse,Adverseevents
2

|

0

|

0

<HTML>
<CITATION> <Bulk Citation> 2022060968508152 false

Published：2022-08-14

⁰

Latest Issue

Issue Browsing Column Browsing

The effect of 3% diquafosol on the improvement of ocular surface post cataract surgery: A meta-analysis for time of intervention Cover Article Back Cover Article Enhanced Publication

Eyelid squamous cell carcinoma in the setting of epidermodysplasia verruciformis (EV) diagnosed by next-generation sequencing: A case report and literature review Cover Article Back Cover Article Enhanced Publication

Changes of Beclin-1 and ULK1 in retina of mice model in oxygen-inducedretinopathy Cover Article Back Cover Article Enhanced Publication

Efficacy and safety of monoclonal antibodies in neuromyelitis optica spectrum disorders: A survival meta-analysis of randomized controlled trials Cover Article Back Cover Article Enhanced Publication